AstraZeneca wins FDA approval for Enhertu in early breast cancer

2 outlets in our directory ran this story, first to last over 9 hours. All of the coverage we found sits in one bucket: centre. That one-sidedness is itself worth noticing.

• ▪ FDA Expands Use of T-DXd in Early HER2+ Breast Cancer — Medscape

Investing.com — News files mainly under finance. We currently carry 6,777 of its stories.